NZ Plans Revamp Of ‘Outdated’ Rules To Attract More Trials
This article was originally published in PharmAsia News
Executive Summary
As part of its planned overhaul of the regulatory framework for medicines and medical devices, the New Zealand government says it intends to 'realize New Zealand's potential as a clinical trial destination' by updating the clinical trial regulations in line with international norms, and extending trial oversight to all therapeutic products.